Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen... Read more
20 Jul 2023
•
5mins
Gout and risk of neurodegenereative diseases, Tenecteplase compared with warfarin, cognitive decline after heart attack
Gout and risk of neurodegenereative diseases, Tenecteplase compared with warfarin, cognitive decline after heart attack
In this week’s podcast, Neurology Today’s editor-in-chief discusses the association between gout and neurodegenerative d... Read more
6 Jul 2023
•
5mins
Similar Podcasts
Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson’s, gene variant confers resilience against autosomal dominant Alzheimer’s.
Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson’s, gene variant confers resilience against autosomal dominant Alzheimer’s.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the FDA approval of an antipsychotic for agitation i... Read more
15 Jun 2023
•
5mins
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregn... Read more
1 Jun 2023
•
5mins
Assay detects Parkinson’s before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE
Assay detects Parkinson’s before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE
In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study reporting a gene assay detected Parkinso... Read more
18 May 2023
•
5mins
Anticoagulants for patients with dementia and Afib, tau levels in women taking hormone replace therapy, neurohumanities programs for neurology residents.
Anticoagulants for patients with dementia and Afib, tau levels in women taking hormone replace therapy, neurohumanities programs for neurology residents.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study finding anticoagulants are safe for pat... Read more
4 May 2023
•
5mins
Fertility treatments for women with MS, stroke systems of care, ravalizumab for NMOSD
Fertility treatments for women with MS, stroke systems of care, ravalizumab for NMOSD
In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study finding fertility treatments did not le... Read more
20 Apr 2023
•
5mins
Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the newly approved zavegepant for migraine, the pote... Read more
6 Apr 2023
•
6mins
Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.
Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the increased use of antipsychotics during the pand... Read more
16 Mar 2023
•
6mins
Pregnancy-associated stroke outcomes; a robotic device for shoulder movement in ALS; non-invasive neurostimulation for refractory seizures.
Pregnancy-associated stroke outcomes; a robotic device for shoulder movement in ALS; non-invasive neurostimulation for refractory seizures.
In this week’s podcast, Neurology Today’s editor-in-chief discusses long-term adverse outcomes from pregnancy-associate... Read more
2 Mar 2023
•
5mins